New Key Statistics Module, Z-Score and F-Score
NAS:VRDN Key Ratios
| Market Cap $ M | 1,907.38 |
| Enterprise Value $ M | 1,501.71 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.84 |
| Price/Sales | 4,826.88 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -4.25 |
| Beneish M-Score | -5.98 |
| 10-y EBITDA Growth Rate % | 27.00 |
| 5-y EBITDA Growth Rate % | 28.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -6.66 |
| EV-to-EBITDA | -6.68 |
| PEG | -- |
| Shares Outstanding M | 76.36 |
| Net Margin (%) | -79,185.76 |
| Operating Margin % | -87,078.47 |
| Pre-tax Margin (%) | -79,185.76 |
| Quick Ratio | 15.82 |
| Current Ratio | 15.82 |
| ROA % (ttm) | -47.78 |
| ROE % (ttm) | -52.95 |
| ROIC % (ttm) | -1,788.90 |
| Dividend Yield % | -- |
| Altman Z-Score | 17.57 |
VRDN Number of Guru Trades
VRDN Volume of Guru Trades
Gurus Latest Trades with NAS:VRDN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VRDN is held by these investors
Total 1
Viridian Therapeutics Inc Insider Transactions
No Available Data
News about NAS:VRDN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers